Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

A research team has made a significant finding that sheds new light on dementia with Lewy Bodies (DLB). The team was led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology ...

A research team led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology at Toho University has made a significant finding that sheds new light on Dementia with Lewy Bodies ...

The study revealed that individuals with Dementia with Lewy Bodies (DLB) have notably lower levels of α-synuclein in their red blood cells compared to healthy individuals or patients with ...

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't help but wonder: Will I be among them?

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Dementia with lewy bodies (“DLB”) patients, treated with 200mg of nilotinib had statistically significant improvement in cognitive function compared to placebo. MCLEAN, VA, UNITED STATES, June ...

“This large observational study looked at health records of over 26,000 people in the US diagnosed with chronic lower back pain and who were prescribed gabapentin within a 10-year period. They found ...

Cognition Therapeutics, Inc. Schedules End-of-Phase 2 Meeting with FDA for Alzheimer's Treatment and Files Applications for Breakthrough Status in Dementia with Lewy Bodies ...

On closer inspection, however, a reduced risk associated with semaglutide was only found with vascular dementia (the second-most common form of dementia), and not with Lewy body dementia or ...